Medical Condition News

RSS

Researchers identify protein in brain that plays critical role in memory loss seen in Alzheimer's patients

Cleveland Clinic researchers have identified a protein in the brain that plays a critical role in the memory loss seen in Alzheimer's patients, according to a study to be published in the journal Nature Neuroscience and posted online today.

20 Jan 2014

Researchers conduct study to evaluate musculoskeletal pain outcomes after motor vehicle collision

A new study led by University of North Carolina School of Medicine researchers is the first large prospective study to evaluate musculoskeletal pain outcomes after motor vehicle collision in the U.S.

20 Jan 2014

Eating high levels of flavonoids found in berries, tea, and chocolate offer protection from type 2 diabetes

Eating high levels of flavonoids including anthocyanins and other compounds (found in berries, tea, and chocolate) could offer protection from type 2 diabetes - according to research from the University of East Anglia (UEA) and King's College London.

20 Jan 2014

Higher levels of physical activity reduces risk of prostate cancer recurrence, mortality

Men who walked at a fast pace prior to a prostate cancer diagnosis had more regularly shaped blood vessels in their prostate tumors compared with men who walked slowly, providing a potential explanation for why exercise is linked to improved outcomes for men with prostate cancer, according to results presented here at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, held Jan. 18-21.

20 Jan 2014

Research findings may offer new therapeutic target for management of Gaucher diseas

What causes brain damage and inflammation in severe cases of Gaucher disease? Little is known about the events that lead to brain pathology in some forms of the disease, and there is currently no treatment available - a bleak outlook for sufferers and their families. Now, scientists at the Weizmann Institute of Science have discovered a new cellular pathway implicated in Gaucher disease.

19 Jan 2014

Telestroke appears to be cost-effective for society

Researchers have found that using telemedicine to deliver stroke care, also known as telestroke, appears to be cost-effective for society. The research was recently published in the American Journal of Managed Care.

19 Jan 2014

New collaboration aims to push cancer diagnostics to the next level

A collaboration between National Cancer Centre Singapore and Clearbridge BioMedics, in partnership with the Pathology Department at Singapore General Hospital has resulted in the establishment of the region's first Circulating Tumour Cell Centre of Research Excellence. This new Centre facilitates the use of circulating tumour cells in clinical diagnostics, in order for new technologies to be applied by healthcare institutions.

19 Jan 2014

Strontium should no longer be used for osteoporosis treatment, warns European Agency

All persons taking strontium supplements are warned that significant risks have been identified. Strontium drugs are not approved for treatment of osteoporosis in the United States. Now, the Risk Assessment Committee of the European Medicines Agency recommended that strontium should no longer be used to treat osteoporosis in Europe. The drugs Protelos/Osseor were specifically named as brand names for strontium ranelate.

19 Jan 2014

University of Huddersfield scientist awarded prestigious Clulow Award by British Pain Society

IN the UK alone, an estimated 7.8 million people have their lives blighted by chronic pain, and 44 per cent are failing to receive an accurate diagnosis and appropriate treatment. Now, a University of Huddersfield scientist, backed by funding from the British Pain Society and crucial support from the National Institute of Health Research, is embarking on research which aims to help doctors diagnose and treat one of the least understood but most widespread sources of chronic suffering.

18 Jan 2014

$Japanese MHLW approves ADCETRIS for relapsed or refractory CD30-positive HL and ALCL$

Japanese MHLW approves ADCETRIS for relapsed or refractory CD30-positive HL and ALCL

Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval of ADCETRIS (brentuximab vedotin) from the Japanese Ministry of Health, Labour and Welfare for the treatment of patients with CD30-positive relapsed or refractory Hodgkin lymphoma and anaplastic large cell lymphoma.

18 Jan 2014

President Obama signs law to increase funding for Alzheimer's research, education

At the urging of the Alzheimer's Association and its more than 600,000 advocates, the funding bill signed into law today by President Obama contained an unprecedented $122 million increase for Alzheimer's research, education, outreach and caregiver support. The Alzheimer's Association applauds the Obama administration for calling for increased Alzheimer's funding in the President's Fiscal Year 2014 budget and Congress for providing funding to enable the continued, effective implementation of the National Plan to Address Alzheimer's Disease.

18 Jan 2014

ARIAD Pharmaceuticals' Iclusig now commercially available to patients in the U.S.

ARIAD Pharmaceuticals, Inc. today announced the commercial availability of Iclusig (ponatinib) for adult patients with refractory chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia in the United States. ARIAD has begun shipping Iclusig to Biologics, Inc., its exclusive specialty pharmacy, which is now filling prescriptions from physicians and distributing the cancer medicine to patients.

18 Jan 2014

Tumor profiling study of colorectal cancer to be presented at 2014 Gastrointestinal Cancers Symposium

Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of personalized medicine, will present a large international tumor profiling study of colorectal cancer at the 2014 Gastrointestinal Cancers Symposium this week in San Francisco, Calif. With more than 7,000 patients comprehensively profiled by Caris Molecular Intelligence, this study represents the largest, multi-national analysis in a single laboratory setting of the main molecular anomalies in colorectal cancer.

18 Jan 2014

Findings suggest possible clinical uses of ecstasy in treating anxiety and PTSD

Brain imaging experiments have revealed for the first time how ecstasy produces feelings of euphoria in users.

17 Jan 2014

FDA approves New Drug Application for PENNSA 2%

Mallinckrodt today announced that the U.S. Food and Drug Administration has approved the New Drug Application for PENNSAID (diclofenac sodium topical solution) 2% w/w. PENNSAID 2% is a topical non-steroidal anti-inflammatory drug approved for use in the treatment of the pain of osteoarthritis of the knee(s).

17 Jan 2014

Patient's EMR coupled with pharmacist intervention improves preventative care of shingles

While people over the age of 60 account for more than half of all shingles cases, less than 15% get the vaccination that helps prevent the blistering skin rash, which can cause lingering nerve pain.

17 Jan 2014

Pulmonary Fibrosis Foundation selects UofL for newly established Care Center Network

The University of Louisville is one of nine pilot sites selected by the Pulmonary Fibrosis Foundation for its newly established Care Center Network and the PFF Patient Registry program. Rafael Perez, M.D., director of the UofL Interstitial Lung Disease program in the Division of Pulmonary, Critical Care & Sleep Disorders Medicine, will lead the UofL site.

17 Jan 2014

U of T researchers find no evidence to support 'blood-type' diet theory

Researchers from the University of Toronto have found that the theory behind the popular blood type diet--which claims an individual's nutritional needs vary by blood type--is not valid. The findings are published this week in PLoS One.

17 Jan 2014

Researcher finds possible way to unravel misfolded proteins by reprogramming yeast protein

At the heart of brain diseases such as amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease is protein misfolding, in which distorted proteins are unable to perform their normal functions. At present, there is no known way to reverse protein misfolding.

17 Jan 2014

Researchers managed to replicate human pancreatic beta cells in mouse model

Klaus Kaestner, PhD, professor of Genetics and postdoctoral fellow Dana Avrahami, PhD, from the Perelman School of Medicine, University of Pennsylvania, published a study this week in the Journal of Clinical Investigation, with colleague Benjamin Glaser, MD, from the Hadassah-Hebrew University Medical Center, Jerusalem, and colleagues. In this study, they were able to replicate human pancreatic beta cells - the cells in our body that produce the critical hormone insulin - in a mouse model in which donor cells were transplanted. The newly replicated cells retained features of mature beta cells and showed a physiological response to glucose.

17 Jan 2014

Medical Condition News

Researchers identify protein in brain that plays critical role in memory loss seen in Alzheimer's patients

Researchers conduct study to evaluate musculoskeletal pain outcomes after motor vehicle collision

Eating high levels of flavonoids found in berries, tea, and chocolate offer protection from type 2 diabetes

Higher levels of physical activity reduces risk of prostate cancer recurrence, mortality

Research findings may offer new therapeutic target for management of Gaucher diseas

Telestroke appears to be cost-effective for society

New collaboration aims to push cancer diagnostics to the next level

Strontium should no longer be used for osteoporosis treatment, warns European Agency

University of Huddersfield scientist awarded prestigious Clulow Award by British Pain Society

Japanese MHLW approves ADCETRIS for relapsed or refractory CD30-positive HL and ALCL

President Obama signs law to increase funding for Alzheimer's research, education

ARIAD Pharmaceuticals' Iclusig now commercially available to patients in the U.S.

Tumor profiling study of colorectal cancer to be presented at 2014 Gastrointestinal Cancers Symposium

Findings suggest possible clinical uses of ecstasy in treating anxiety and PTSD

FDA approves New Drug Application for PENNSA 2%

Patient's EMR coupled with pharmacist intervention improves preventative care of shingles

Pulmonary Fibrosis Foundation selects UofL for newly established Care Center Network

U of T researchers find no evidence to support 'blood-type' diet theory

Researcher finds possible way to unravel misfolded proteins by reprogramming yeast protein

Researchers managed to replicate human pancreatic beta cells in mouse model

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News